The German federal government is to acquire a 23% stake in messenger RNA-based drug developer Curevac via a €300m investment, joining the shareholder base alongside existing investor Dievini Hopp.
Aliter Capital formed North via a buy-and-build strategy for portfolio company Boston Networks
GP invested EUR 60m for a minority stake in the environmental commodities trading platform in 2018
European growth technology investor held a final close for its debut vehicle in 2018 on EUR 400m
Alto Capital III fund secured a majority stake in the food products manufacturer in 2017